The PSA level of the untreated testosterone-induced BPH group was significantly (P<0.05) higher than the normal control group while the finasteride-treated group showed a significant (P<0.05) decrease in PSA level compared with the untreated testosterone-induced BPH group. This evidence concerns the gene KLK3 and benign prostatic hyperplasia.